Wave Life Sciences (WVE) EBT Margin Growth (3y) (2018 - 2026)
Wave Life Sciences (WVE) EBT Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | 14,376.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,376.00 |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 164,987.00 |
| Jun 30, 2024 | 122,928.00 |
| Dec 31, 2023 | 25,796.00 |
| Sep 30, 2023 | 97,278.00 |
| Jun 30, 2023 | 124,342.00 |
| Mar 31, 2023 | 92,942.00 |
| Dec 31, 2022 | -110,738.00 |
| Sep 30, 2022 | -1.20 Mn |
| Jun 30, 2022 | -1.05 Mn |
| Mar 31, 2022 | -70,013.00 |
| Dec 31, 2021 | -93,293.00 |
| Sep 30, 2021 | 82,044.00 |
| Jun 30, 2021 | -66,079.00 |
| Dec 31, 2020 | 250,813.00 |
| Sep 30, 2020 | 101,107.00 |
| Jun 30, 2020 | 87,206.00 |
| Mar 31, 2020 | 407,689.00 |
| Dec 31, 2019 | 39,464.00 |